Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
National Institutes of Health (NIH)
Total funding amount: $150,000 per year
Maximum project period: 3 years
To support exploratory research projects focused on developing innovative technologies for improving the quality and handling of cancer-relevant biospecimens.
National Cancer Institute (NCI)
Researchers in cancer biology, clinical diagnosis, and treatment
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local governments, state governments, and tribal governments.
Non-domestic (non-U.S.) entities are also eligible to apply.
Open to U.S. and non-U.S. organizations.
Focus on early-stage development of innovative technologies for biospecimen handling.
Projects must address unmet needs in cancer research.
Application budgets are limited to $150,000 per year in direct costs.
Application deadline: October 3, 2025.
Earliest start date: April 4, 2025.
No restrictions on prior grant funding mentioned.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on significance, innovation, rigor, and feasibility.
Applications will undergo scientific peer review and receive a written critique.
Scientific and technical merit of the proposed project will be considered.
Projects must include quantitative performance measures.
Applications proposing traditional biological-hypothesis driven research will not be reviewed.
Projects that address cancer health disparities are encouraged.
Innovative technologies with high potential impact are prioritized.
Demonstrating innovative capabilities and addressing unmet needs in cancer research.
Avoid submitting applications that lack novelty in technical capabilities.
Engage with NIH contacts for guidance on project alignment with funding priorities.
Highlight the transformative potential of the proposed technology.